Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00430612 · ClinicalTrials.gov registry record
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)
A clinical trial of Myocardial Infarction, sponsored by Northwestern University.
- Completed
- Registry status
- 7,057
- Enrollment target
- 20
- Study locations
NCT00430612: Completed study of Myocardial Infarction, sponsored by Northwestern University.
NCT00430612 is a study of Myocardial Infarction that has completed, run by Northwestern University. The registered enrollment target is 7,057 participants, above the 4,571-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (54% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00430612, a study of Myocardial Infarction, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 7,057 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose will be predictive of survival. Exploratory analyses: Gender and racial effects-gender and race are, similarly, hypothesized to be predictive of post-MI survival. The existence of interactions between gender and beta-blocker effect as well as race and beta-blocker effect will also be evaluated.
Primary Outcome
Compare Kaplan Meier survival curves for the following 5 beta-blocker dose groups: No beta-blockers - 12.5% (\>0 - 12.5%) 25% (\>12.5 - 25%) - 50% (\>25 - 50%) Full Dose (\>50%)
Conditions Studied
Study Locations (20)
New York
- Winthrop University Hospital - Bethpage
- Maimonides Medical Center - Brooklyn
- Strong Memorial Hospital (University of Rochester School of Medicine) - Rochester
California
- MemorialCare Heart and Vascular Institute - Long Beach Memorial Medical Center - Long Beach
- West Los Angeles VA Medical Center - Los Angeles
Florida
- Baptist Cardiac and Vascular Institute - Miami
- Orlando Regional Medical Center - Orlando
Texas
- Amarillo Heart Clinic Research Institute, Inc. - Amarillo
- Austin Heart PLLC - Austin
Arkansas
- Little Rock Cardiology Clinic - Little Rock
Connecticut
- Bridgeport Hospital - Bridgeport
Illinois
- Northwestern Memorial Hospital - Chicago
Indiana
- Clarian Health/Methodist Research Institute - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,057 participants |
| Start Date | 2009-05 |
| Est. Completion | 2015-10 |
What the finished NCT00430612 record still lists
NCT00430612 is an observational study that tracks outcomes without assigning an intervention. Its 7,057 participants enrollment target places it among the larger protocols in the corpus, above the 4,571-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (54% higher).
The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT00430612 names 20 study sites across 15 states, led by New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00430612 about?
NCT00430612 is a clinical study titled "The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)". The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose wil...
What is the current status of trial NCT00430612?
This trial is currently completed. The enrollment target is 7,057 participants. The study started on 2009-05. Estimated completion is 2015-10.
What conditions does trial NCT00430612 study?
This clinical trial studies the following conditions: Myocardial Infarction.
Who is sponsoring clinical trial NCT00430612?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00430612 being conducted?
This trial has 20 study locations across Arkansas, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00430612's enrollment target sits among peer trials
7,057 7th of 64 higher than 58 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia